Adherence to recommendations by infectious disease consultants and its influence on outcomes of intravenous antibiotic-treated hospitalized patients by Fariñas Álvarez, María del Carmen et al.
Fariñas et al. BMC Infectious Diseases 2012, 12:292
http://www.biomedcentral.com/1471-2334/12/292RESEARCH ARTICLE Open AccessAdherence to recommendations by infectious
disease consultants and its influence on
outcomes of intravenous antibiotic-treated
hospitalized patients
María-Carmen Fariñas1*, Gabriela Saravia1, Jorge Calvo-Montes2, Natividad Benito3, Juan-José Martínez-Garde4,
Concepción Fariñas-Alvarez5, Lorenzo Aguilar6, Ramón Agüero7, José-Antonio Amado8,
Luis Martínez-Martínez2,9 and Manuel Gómez-Fleitas10Abstract
Background: Consultation to infectious diseases specialists (ID), although not always performed by treating
physicians, is part of hospital’s daily practice. This study analyses adherence by treating physicians to written ID
recommendations (inserted in clinical records) and its effect on outcome in hospitalized antibiotic-treated patients
in a tertiary hospital in Spain.
Methods: A prospective, randomized, one-year study was performed. Patients receiving intravenous antimicrobial
therapy prescribed by treating physicians for 3 days were identified and randomised to intervention (insertion of
written ID recommendations in clinical records) or non-intervention. Appropriateness of empirical treatments
(by treating physicians) was classified as adequate, inadequate or unnecessary. In the intervention group, adherence
to recommendations was classified as complete, partial or non-adherence.
Results: A total of 1173 patients were included, 602 in the non-intervention and 571 in the intervention group
[199 (34.9%) showing complete adherence, 141 (24.7%) partial adherence and 231 (40.5%) non-adherence to
recommendations]. In the multivariate analysis for adherence (R2 Cox=0.065, p=0.009), non-adherence was
associated with prolonged antibiotic prophylaxis (p=0.004; OR=0.37, 95%CI=0.19-0.72). In the multivariate analysis
for clinical failure (R2 Cox=0.126, p<0.001), Charlson index (p<0.001; OR=1.19, 95%CI=1.10-1.28), malnutrition
(p=0.006; OR=2.00, 95%CI=1.22-3.26), nosocomial infection (p<0.001; OR=4.12, 95%CI=2.27-7.48) and length of
hospitalization (p<0.001; OR=1.01, 95%CI=1.01-1.02) were positively associated with failure, while complete
adherence (p=0.001; OR=0.35, 95%CI=0.19-0.64) and adequate initial treatment (p=0.010; OR=0.39, 95%CI=0.19-0.80)
were negatively associated.
Conclusions: Adherence to ID recommendations by treating physicians was associated with favorable outcome, in
turn associated with shortened length of hospitalization. This may have important health–economic benefits and
stimulates further investigation.
Trial registration: Current Controlled Trials ISRCTN83234896. http://www.controlled-trials.com/isrctn/
sample_documentation.asp
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Antibiotics account for one-third of hospital’s pharmacy
budget, with between 25% and 50% hospitalized patients
receiving antibiotics [1]. In hospitals, nearly all physi-
cians prescribe antibiotics, and their prescriptions are
influenced by characteristics of patient population, phy-
sician’s prescribing habits and local resistance patterns
[2]. Inappropriate use of antibiotics results in a variety of
adverse outcomes: narrow coverage increases the risk of
therapeutic failure whereas broad coverage increases the
risk of superinfection [3].
Antimicrobial stewardship by multidisciplinary teams
[4] (including preventive medicine specialists, pharma-
cists, pharmacologists, microbiologists, infectious dis-
eases specialists -IDs- and infection control nurses) is of
increasing importance in the last decades due to the
growing problem of nosocomial infections and resistance
to antibiotics [5]. This together with the increasing pro-
portion of hospitalized elderly patients with co-
morbidities (that more frequently suffer infections) have
contributed to the demand for more infectious disease
services [6]. IDs can improve effectiveness by recom-
mending a more appropriate antibiotic use [7], and their
positive impact on patient care and infection control has
been demonstrated [8,9]. The effectiveness of infectious
disease consultations depends not only on clinically as-
tute recommendations, but also on the adherence to
them, since without it even the best recommendations
are rendered ineffective [10]. Consultation to IDs, al-
though not always performed by treating physicians, is
part of hospital’s daily practice. The easy and rapid access
to IDs has been identified as important factor facilitating
consultation instead of seeking other sources of informa-
tion, which are more time-consuming [7]. For this reason
insertion of written ID recommendations in clinical
records seems an strategy to be considered for rapid
access to ID recommendations by treating physicians.
The aim of the present study was to investigate adher-
ence by treating physicians to written ID recommenda-
tions inserted in clinical records and the potential
influence that this adherence had on clinical outcome in
hospitalized intravenous antibiotic-treated patients in a
tertiary university teaching hospital in Spain.
Patients and methods
A prospective, randomized, controlled study was carried
out from January 2008 to December 2008 in the Hos-
pital Universitario Marques de Valdecilla, Santander,
Spain, a tertiary universitary hospital with 874 beds.
The study protocol was approved by the Ethics Com-
mittee of the Autonomous Community of Cantabria
(IFIMAV, Spain), the Fondo de Investigaciones Sanitarias
[Registered number: FIS PI06/90094], and the Instituto
de Formación e Investigación Marqués de Valdecilla(IFIMAV) [Registered number: API 06/03]. The patient’s
informed consent was waived because the study was
directed to treating physicians, not to patients, since the
primary objective of the study was to assess adherence
by treating physicians to ID recommendations using a
new method described below. Potential influence of ad-
herence by treating physicians on patient's outcomes
was only secondarily assessed. The possibility of ID con-
sultations is part of normal practice in the hospital, and
as in routine practice, treating physicians participating in
the study could ask for ID oral consultation at any time.
Patients admitted in General Surgery, Pneumology
and Endocrinology departments that were receiving
intravenous antimicrobial therapy prescribed by their
responsible physicians for 3 days were identified by the
Pharmacy department. The ID team was daily con-
tacted and patients were randomised by groups (strati-
fied randomization by clinical units) to intervention or
non-intervention using the EPIDAT 3.1 programme
(Dirección Xeral de Saúde Pública, Xunta de Galicia &
Organización Panamericana de la Salud. Santiago de
Compostela, Coruña, Spain, 2003). Interventions con-
sisted of insertion in medical records of written treat-
ment recommendations by an ID physician based on
International [11-13] and Spanish [14-16] treatment
guidelines adapted to local data on antimicrobial sus-
ceptibility after examination of patients, clinical records
and microbiological data (if any) for each patient in the
intervention group. Written recommendations (in spe-
cifically designed study forms) were inserted in the
patient’s records in order to make it available to treat-
ing physicians, with a statement indicating availability
for oral consultation if desired. Consultation was also
available as part of daily practice for physicians treating
patients in the non-intervention group (without inser-
tion of written recommendations), but in the case of
consultation the patient was withdrawn from the study.
Paediatric patients, chronic dialysis patients, those re-
ceiving oral antibiotic therapy and those in which a
member of the ID department had prescribed the ini-
tial antimicrobial regimen, were excluded.
Demographic and clinical data (including comorbid-
ities), reason for antibiotic administration, regimen of
antibiotic treatment, imaging and microbiological data,
and microbiological and clinical outcomes were recorded
both for patients in the intervention and non-intervention
groups. The Charlson comorbidity index unadjusted by
age [17] (age and sex were considered as separate vari-
ables), and the McCabe score [18] were calculated. Regi-
mens of antibiotic treatment were classified as empirical,
microbiologically-based or prolonged prophylaxis (anti-
biotic prophylaxis administered for >24 hours). Length
of hospitalization (time from admission to discharge/
death) was calculated. Patients with definite infection
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without microbiological documentation. Infection was
considered as nosocomial when signs/symptoms
initiated 48-72h after admission and as healthcare-
associated infection if infection occurred in patients who
came from nursing homes or chronic care centres, had
domiciliary hospitalization, had attended the hospital for
oncological chemotherapy or had been hospitalized
within the previous 30 days.
The appropriateness of empirical treatments pre-
scribed by treating physicians (physicians of the primary
service) was assessed and treatments were classified as
adequate (agree with antibiotic choice, dosage, dosing
interval and duration of treatment) or inadequate. Treat-
ments were considered inadequate when one or several
criteria following the Erbay’s modification [19] of Kunin’s
criteria [20] were met. When IDs disagreed with the
need for an antibiotic, treatments were classified as
“unnecessary” by assigning a new category and thus
eliminating this criterion from the Erbay’s category “in-
adequate”. In the intervention group, the degree of ad-
herence to intervention was assessed at day +7 and +10
(from initiation of intravenous antibiotic treatment) and
classified as complete (administration within 24h after
consultation of the recommended antibiotic therapy
with deviations lower than 20% for the dose and lower
than ±30% for treatment duration), partial (administra-
tion of the recommended antibiotic therapy with
deviations greater than 20% for the dose and/or
greater than ±30% for duration and/or initiation be-
tween 24h and 48h after consultation) or non-
adherence (non prescription of the recommended regi-
men or initiation after 48h from consultation). When
the recommended duration of treatment was longer
than 10 days, adherence was assessed at discharge.
Patients were followed during hospitalisation and at
discharge they were clinically evaluated as “clinical
success” (cure or improvement) or “clinical failure”
(absence of improvement, worsening or death during
hospitalization). Cure was considered when patients
were discharged from the hospital with resolution of
acute signs and symptoms of infection and improve-
ment when patients were discharged from the hospital
with oral antibiotic treatment. Patients with an initial
positive culture and at least one follow-up culture were
considered microbiologically evaluable and were evalu-
ated as “microbiological success” (eradication) or “micro-
biological failure” (persistence or superinfection) at
discharge.
Comparisons between proportions were performed by
the χ2 test and the Fisher’s exact test, when necessary.
For quantitative variables, since data did not showed
normality in the Kolmogorov-Smirnoff test, the Kruskal-
Wallis and Mann–Whitney tests, when necessary, wereused. Bivariate analyses were performed comparing all
variables between the group of patients with treatment
showing adherence (complete adherence or complete
plus partial adherence) versus those showing non-adher-
ence, as well as between the group of patients showing
clinical success versus those showing clinical failure. In
order to avoid false associations in multiple comparisons
in the bivariate analyses, the Bonferroni correction was
applied and the p<0.001 was considered statistically sig-
nificant to minimize type 1 error.Two different logistic
regression models (step–wise procedure) were per-
formed: one using “adherence” as dependent variable
and another using “clinical failure”. In both multivariate
analyses, independent variables were those showing dif-
ferences (p≤0.1) in the previous bivariate analyses per-
formed. In the multivariate analysis using “clinical
failure” as dependent variable, adherence (both consid-
ered as complete adherence and as complete + partial
adherence) was one of the independent variables intro-
duced. Interactions and linear dependence between in-
dependent variables were previously controlled.
Statistical analyses were performed using SPSS v 18
programme (SPSS Inc, Chicago IL). The models showing
the highest R2 were considered.
Results
Disposition of patients
A total of 1266 adult patients receiving intravenous
antibiotic treatment for 3 days were identified by the
Pharmacy department. Of them, 1185 patients were
randomized and 1173 antibiotic-treated patients were fi-
nally considered, 571 patients in the intervention group
and 602 patients in the non-intervention group. Figure 1
shows the study flow-chart including reasons for exclu-
sion and withdrawns. Among the 571 patients in the
intervention group, 199 (34.9%) showed complete ad-
herence to the recommendation, 141 (24.7%) partial ad-
herence and 231 (40.5%) non-adherence.
Baseline demographic and clinical characteristics
Table 1 shows baseline demographic data, comorbidity
and prognostic indices of patients included in the
study distributed by study groups. Comorbidities
present in >10% study patients were: previous surgery
(62.0%), malignancies (41.2%), diabetes mellitus (39.7%),
heart disease (38.5%), chronic respiratory insufficiency
(32.9%), renal insufficiency (30.6%), immunosuppressive
therapy (17.8%), smokers (14.1%) and alcohol intake
(12.1%), without significant differences between the in-
tervention and the non-intervention groups. The group
of patients with intervention showed higher, although
non-significant, Charlson index (p=0.006). When compar-
ing groups by adherence to recommendations (complete
versus partial versus non-adherence) significant differences
12  patients with ID 
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Figure 1 Study flow-chart.
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13.4%, p=0.006) and of patients with chronic respiratory in-
sufficiency (45.2% versus 32.9%, p=0.009) was non-
significantly higher in the group of patients with complete




Age (years; mean ± SD) 64.9 ± 17.6 64.7 ± 1
≤65 90 (45.2) 69 (48.
66-75 38 (19.1) 33 (23.
>75 71 (35.7) 39 (27.
Males 127 (63.8) 91 (64.
Coming from healthcare facilities 47 (23.6) 26 (18.
Prior hospitalization (previous 30 days) 56 (28.1) 41 (29.
Prior hospitalization (previous 90 days) 81 (40.7) 53 (37.
Ward of admission (Surgical) 102 (51.3) 89 (63.
Charlson (mean ± SD) 2.26 ± 2.04 2.74 ± 2
≤1 82 (41.2) 53 (37.
2 44 (22.1) 23 (16.
3 34 (17.1) 20 (14.
≥4 39 (19.6) 45 (31.
Mc Cabe (Fatal) 64 (32.2) 55 (39.
Reason for admission (infectious disease) 102 (51.3) 68 (48.
ap<0.001 versus complete adherence.
Data expressed as n (%) except where indicated.percentage of patients with previous surgery was also non-
significantly higher (44.2% versus 59.3%, p=0.002) in the
non-adherence group.
In relation to wards of admission, a significant higher




5.8 64.8 ± 17.8 64.8 ± 17.2 65.0 ± 17.2
9) 99 (42.8) 258 (45.2) 272 (45.2)
4) 60 (26.0) 131 (22.9) 128 (21.3)
7) 72 (31.2) 182 (31.9) 202 (33.5)
5) 142 (61.5) 360 (63.0) 375 (62.3)
4) 63 (27.3) 136 (23.8) 103 (17.1)
1) 76 (32.9) 173 (30.3) 150 (24.9)
6) 89 (38.5) 223 (39.1) 184 (30.6)
1) 158 (68.4) a 349 (61.1) 423 (70.3)
.38 2.38 ± 2.15 2.43 ± 2.18 2. 09 ± 2.10
6) 90 (39.0) 225 (39.4) 293 (48.7)
3) 42 (18.2) 109 (19.1) 111 (18.4)
2) 36 (15.6) 90 (15.8) 69 (11.5)
9) 63 (27.3) 147 (25.7) 129 (21.4)
0) 72 (31.2) 191 (33.4) 201 (33.4)
2) 111 (48.1) 281 (49.2) 299 (49.7)
Table 2 Microbiological tests [n (%)] and isolates (>10%) among those with positive cultures
Intervention Non intervention
Complete Partial Non adherence Total
N 199 141 231 571 602
Patients with no microbiological tests 42 (21.1) 35 (24.8) 86 (37.2) a 163 (28.5) 212 (35.2)
Patients with serology 17 (8.5) 3 (2.1) 9 (3.9) 29 (5.1) 22 (3.7)
Patients with culture 140 (70.4) 103 (73.1) 136 (58.8) 379 (66.4) 368 (61.1)
Positive cultures 80 (57.1) 65 (63.1) 80 (58.8) 225 (59.3) 177 (48.1)
E. coli 16 (20.0) 17 (26.2) 16 (20.0) 49 (21.8) 43 (24.3)
S. pneumoniae 13 (16.3) 6 (9.2) 9 (11.3) 28 (12.4) 21 (11.9)
P. aeruginosa 11 (13.8) 7 (10.8) 10 (12.5) 28 (12.4) 13 (7.3)
ap<0.001 versus complete adherence.
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51.3%, p<0.001).
Of the 1173 patients included, definitive infection was
diagnosed in 913 (77.8%) patients, without differences in
type and site of infections between groups. Community-
acquired infections were the most frequent (597 out of
913, 65.4%) followed by nosocomial infections (277 out
of 913, 30.3%). Healthcare associated infections only
represented 4.3% (39 out of 913). By site of infection,
lower respiratory tract infections were the most frequent
(30.3%) followed by gastrointestinal infections (22.9%)
and surgical site infections (22.1%).
Baseline microbiological data
Microbiological tests were significantly (p<0.001) more
frequently requested in the group of patients with





Empirical 186 (93.5) 130 (92.2
Prolonged Prophylaxis 13 (6.5) 10 (7.1)
Microbiologically-based 0 (0.0) 1 (0.7)
Antibiotic regimens including
One compound 119 (59.8) 93 (66.0
Two or more compounds 80 (40.2) 48 (34.0
Treatment initiation in Emergency room 56 (28.1) 40 (28.4
Treatment evaluation (initial) 199 141
Adequate 70 (35.2) 22 (15.6
Inadequate 129 (64.8) 115 (81.6
Unnecessary 0 (0.0) 4 (2.8)
Modification of initial treatment 129 (64.8) 52 (36.9
ap<0.001 versus complete adherence; bp<0.001 versus Total intervention; cp<0.001(Table 2). Of the 747 initial cultures requested, 402
(53.8%) were positive, with non-significantly higher per-
centage of positive cultures (59.3% versus 48.1%
p=0.002) in the intervention group. Overall, Escherichia
coli (22.9%), Streptococcus pneumoniae (12.2%) and
Pseudomonas aeruginosa (10.2%) were the most frequent
species isolated.
Characteristics of antibiotic treatments prior to ID
recommendations
Of the 1173 patients included, 209 (17.8%) patients
received antibiotics as prolonged prophylaxis, with sig-
nificantly higher percentage of patients receiving
prophylaxis in the non-intervention group (Table 3).
The percentage of initial treatments classified as ad-
equate was significantly higher in the intervention versus
non intervention group, in the complete versus partialore intervention [n (%)]
Non intervention
l Non adherence Total
231 571 602
) 183 (79.2) 499 (87.4) 458 (76.1)
45 (19.5) a 68 (11.9) 141 (23.4) b
3 (1.3) 4 (0.7) 3 (0.5)
) 170 (73.6) 382 (66.9) 451 (74.9)
) 61 (26.4) 189 (33.1) 151 (25.1)
) 65 (28.1) 161 (28.2) 97 (16.1) b
231 571 602
) a 4 (1.7) a,c 96 (16.8) 60 (10.0)
) a 222 (96.1) a,c 466 (81.6) 531 (88.2)
5 (2.2) 9 (1.6) 11 (1.8)
) a 33 (14.3) a,c 214 (37.5) 105 (17.4) b
versus partial adherence.
Table 4 Clinical and microbiological outcome [n (%)] of patients included in the study
Intervention Non intervention
Complete Partial Non adherence Total
N 199 141 231 571 602
Length of hospitalization (days; mean ±SD) 24.1 ± 29.3 26.5 ± 24.3 20.2 ± 18.8 23.1 ± 24.3 20.3 ± 33.8
Clinical outcome
Cure + improvement 184 (92.5) 121 (85.8) 185 (80.1) a 490 (85.8) 493 (81.9) a
Death 4 (2.0) 5 (3.5) 12 (5.2) 21 (3.7) 30 (5.0)
Microbiological outcome
No. patients microbiologically evaluableb 36 (18.1) 29 (20.6) 40 (17.3) 105 (18.4) 85 (14.1)
Eradication 25 (69.4) 11 (37.9) 8 (20.0) a 44 (41.9) 18 (21.2) a,c
ap<0.001 versus complete adherence; bpatients with initial positive culture and at least one follow-up culture; cp<0.001 versus Total intervention.
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partial adherence versus non-adherence group (Table 3).
The most frequent reasons for classifying treatments as
inadequate were inadequacy of treatment duration
(48.8%) and lack of adequate dosage adjustment in
patients with chronic renal or hepatic insufficiency
(33.8%). Significant differences in the percentage of inad-
equate treatment duration were found between the
intervention and non-intervention groups (38.4% versus
58.6%, p<0.001) and between complete adherence and
non-adherence (16.1% versus 57.1%, p<0.001).
Modifications of initial treatments were significantly
(p<0.001) more frequent in the intervention group, and
within this group, in the group of complete versusTable 5 Factors predicting clinical failure
Success
N 983
Age (mean ± SD) 64.1 ± 17.6
Coming from healthcare facilities 183 (18.6)
Prior hospitalization (previous 30 days) 255 (25.9)
Charlson index 2.07 ± 2.07
Heart failure 358 (36.4)
Renal insufficiency 281 (28.6)
Diabetes 408 (41.5)
Malignancies 384 (39.0)
Immunosuppressive therapy 178 (18.1)
Malnutrition 74 (7.5)
Nosocomial infection 187 (25.3)
Microbiological tests 652 (66.3)
Complete adherence 184 (18.7)
Treatment initiated in Emergency room 777 (79.0)
Adequate initial treatment 147 (15.0)
Modification of initial treatment 306 (31.1)
Length of hospitalization 18.9 (27.0)
It shows only significant variables in the bivariate analysis. “Clinical failure” was usepartial adherence or versus non-adherence and in the
group of partial adherence versus non-adherence
(Table 3).
Outcome
Table 4 shows length of hospitalization and clinical and
microbiological outcomes of patients included in the
study distributed by study groups. Significantly (p<0.001)
higher percentage of clinical success (cure + improve-
ment) was found in the group of complete adherence
(92.5%) versus non-adherence (80.1%) or versus the
non-intervention group (81.9%). Mortality was 4.3%,
without differences between groups. The percentage of
patients showing microbiological eradication among theFailure P OR
190 Bivariate Multivariate
68.9 ± 14.7 <0.001 p= 0.100
56 (29.5) 0.001 p= 0.215
68 (35.8) 0.005 p= 0.625
3.17 ± 2.16 <0.001 1.19 (1.10-1.28) p<0.001
94 (49.5) 0.001 p= 0.123
86 (45.3) <0.001 p= 0.155
93 (48.9) 0.058 p= 0.744
104 (54.7) <0.001 p= 0.775
47 (24.7) 0.034 p= 0.262
34 (17.9) <0.001 2.00 (1.22-3.26) p=0.006
88 (51.8) <0.001 4.12 (2.27-7.48) p<0.001
160 (84.2) <0.001 p= 0.020
15 (7.9) 0.001 0.35 (0.19-0.64) p=0.001
138 (72.6) 0.051 p= 0.023
9 (4.7) <0.001 0.39 (0.19-0.80) p=0.010
43 (22.6) 0.019 p= 0.140
36.3 (37.4) <0.001 1.01 (1.01-1.02) p<0.001
d as dependent variable.
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higher in the intervention group (41.9% versus 21.2%,
p<0.001) and, within this group, in the group of
complete adherence versus non-adherence (69.4% versus
20.0%, p<0.001).
Factors associated with adherence and clinical outcome
The multivariate analysis using “adherence” as dependent
variable was significant (R2 Cox=0.065, p=0.009), with
adherence negatively associated with prolonged prophy-
laxis (p=0.004; OR=0.37, 95%CI=0.19-0.72).
Table 5 shows significant variables (p<0.1) in the bi-
variate analysis comparing patients showing success with
those showing clinical failure. These variables were those
included in the multivariate analysis using “clinical fail-
ure” as dependent variable and the results are shown in
the Table. The model was significant (R2 Cox=0.126,
p<0.001), with Charlson index (p<0.001; OR=1.19, 95%
CI=1.10-1.28), malnutrition (p=0.006; OR=2.00, 95%
CI=1.22-3.26), nosocomial infection (p<0.001; OR=4.12,
95%CI=2.27-7.48) and length of hospitalization (p<0.001;
OR=1.01, 95%CI=1.01-1.02) associated with clinical
failure. Complete adherence (p=0.001; OR=0.35, 95%
CI=0.19-0.64) and adequate initial treatment (p=0.010;
OR=0.39, 95%CI=0.19-0.80) were negatively associated
with clinical failure.
When the multivariate analysis was performed includ-
ing complete plus partial adherence as independent vari-
able (instead of complete adherence), the multivariate
analysis was also significant (identical R2 Cox) with the
same variables positively or negatively associated with
clinical failure. In the group of patients showing clin-
ical success, complete + partial adherence was 31.0%
while it was 18.4% among patients showing clinical
failure. Complete + partial adherence was negatively
associated with clinical failure (p<0.001; OR=0.43, 95%
CI=0.28-0.67).
Discussion
Most ID specialists believe that it is evident that their
care is valuable, although there are few published studies
on how frequently their recommendations are followed,
or clinical consequences of following them [10,21]. Anti-
microbial stewardship advocates the use of the most
suitable antibiotic in the context of the presenting
clinical condition and specific patient, and its success
rely on coordination and collaboration between health-
care professionals to ensure consistency in approach,
shared knowledge and widespread diffusion of practice
[4]. Among strategies that have been used to decrease
injudicious antimicrobial use, streamlining involves ex-
pert review of patient’s antimicrobial regimens making
recommendations to their providers about stopping or
narrowing therapy [3]. However streamlining is appliedafter antimicrobial therapies have been initiated, allow-
ing some degree of inappropriate exposure in addition
to the potential limitation of effectiveness derived from
the voluntary nature of its compliance [3,22].
There is uncertainty about factors affecting adherence
to recommendations [10]. In the present study, adher-
ence (complete plus partial) was 59.5% or even lower if
we consider only patients with complete adherence
(34.9%). Although the percentage of complete + partial
adherence is within the frame of 53% to 90% reported in
the literature [10,23], complete adherence was lower.
This low adherence in our study is worrying and can be
related to the fact that eligible patients were identified
when they were receiving antibiotic treatment for 3 days,
a fact favoring not to follow recommendations in those
patients with early favorable responses. In the multivari-
ate analysis only prolonged prophylaxis was significantly
associated with non-adherence. This contrast with the
idea of expecting more requests from surgical units since
they are less experienced with infectious diseases [7].
Although the impact of infectious diseases consulta-
tions on actual patient management is difficult to assess
[6], several studies have shown that consultations
optimize antibiotic use in patients receiving intravenous
antimicrobials and are cost-effective [24,25]. In the
present study the group of patients with complete adher-
ence to recommendations showed significant higher
clinical success and eradication among microbiologically
evaluable patients. Not surprisingly, Charlson index,
malnutrition and nosocomial infections were the vari-
ables significantly associated with clinical failure in the
multivariate analysis, but more importantly, adequate
initial treatment and adherence to recommendations
were negatively associated. These last factors are those
that could be influenced by IDs in daily practice. In
addition, microbiological tests were more frequently
requested in patients randomized to intervention, with
higher percentage of positive cultures, suggesting that
ID consultation in addition to antibiotic advice also con-
sciously or unconsciously influenced test request prac-
tices, and possibly led to more appropriate selection of
sites for microbiological tests. These findings in patients
receiving intravenous antibiotic therapy show that ID
consultations not only improve patient’s outcome but
may also result in substantial cost reductions since clin-
ical failure was significantly associated with larger length
of hospitalization. Decreasing the hospital length of stay
by promoting earlier hospital discharge significantly re-
duce overall costs and increase the efficiency and cost-
effectiveness of the hospital [26].
Several study limitations should be taken into consid-
eration when extrapolating results to other settings since
this study was performed in a single hospital, with par-
ticipation of reduced number of specific wards, and only
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at least 3 days of intravenous antibiotic therapy. Prob-
ably local medical routines (differences in IDs daily prac-
tice) could influence extrapolations to other settings.
In conclusion, the method used for intervention (writ-
ten recommendations inserted in clinical records 3 days
after initiation of intravenous therapy) did not achieved
a high degree of adherence despite this method made
recommendations easily available to treating physicians.
It has been reported that direct, personal communica-
tion [27] or the presence at patient’s bedside of ID spe-
cialists [28] would dramatically improved adherence to
recommendations, although this is not always possible
in daily practice. Regardless the low adherence in the
present study, the results showed that adherence to
recommendations were associated with favorable clinical
and microbiological outcomes and shortened length of
hospitalization. The results of the present study stress
the importance of adherence (without it even the best
recommendations are rendered ineffective) [10] and sug-
gest important health–economic benefits. This stimu-
lates further investigation in this field, with different
methodologies and specific groups of patients, since as
has been indicated, the need for physician expertise and
intervention has never been more apparent than at the
present time [29].
Abbreviation
IDs: Infectious Diseases specialists.
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